Abbvie Ltd

AbbVie Ltd is the British subsidiary of the global biopharmaceutical company AbbVie Inc., specialising in immunology, oncology, neuroscience, eye care, and aesthetics. Key UK products include Humira (adalimumab) for autoimmune diseases, Skyrizi (risankizumab) for psoriasis and inflammatory bowel disease, Rinvoq (upadacitinib) for arthritis and atopic dermatitis, Imbruvica (ibrutinib) for blood cancers, and Botox (botulinum toxin) for therapeutic and cosmetic use.